Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Clinical Trials to Validate AI-Driven Drug Repurposing 2026

    Forecasted

    Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.

    Browse similar grants
    AI in Healthcare Research GrantsAI Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Repurposing Research for Chicago 2026: Track 2 – Patient Groups

    Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing existing therapies for unsolved diseases in underserved groups, children, rare disease patients, and military groups.

    Cures Within ReachForecasted May 8, 2027$125,000Forecasted

    Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

    Use mouse models to test existing and investigational drugs for Alzheimer's; focus on drug repositioning and combo therapy development.

    HHS-NIH11Due Feb 8, 2027$5,000,000

    2026 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries

    2026 ReGRoW supports underresourced researchers in low and lower-middle income countries to test repurposed therapies for unsolved diseases, seeking affordable treatments and stronger local research capacity.

    Cures Within ReachForecasted Apr 10, 2027$78,500Forecasted

    2025: ALS Finding a Cure Request for Proposals

    ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.

    ALSFACForecasted May 23, 2027$400,000Forecasted

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.

    NIH ChallengesDue Jan 15, 2027$100,000